Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise

NCT04472494 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
61
Enrollment
INDUSTRY
Sponsor class

Stopped Slow accrual

Conditions

Interventions

Sponsor

Bristol-Myers Squibb